AusBiotech’s substantive submission to the Senate Standing Committee on Economics’ Australian Innovation System inquiry has called for tax reform, support for commercialisation, incentives for commercial thinking and clinical trial reform.
AusBiotech said that public policy plays a critical role in the development of the biotechnology industry: by incentivising desirable behaviours/choices to build Australia’s innovation ecosystem in a global context, such as providing globally competitive tax policy; and in providing support where the ecosystem currently has gaping holes.
